enoxacin has been researched along with Pneumonia in 12 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic activity of ciprofloxacin, enoxacin, and ofloxacin was evaluated in guinea pigs with acute and chronic experimental Pseudomonas aeruginosa pneumonia." | 7.67 | Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia. ( Kemmerich, B; Pennington, JE; Small, GJ, 1986) |
| "A murine model of bacteremic Haemophilus influenzae type b pneumonia was used to evaluate the therapeutic efficacies of the quinolone antimicrobial agents enoxacin and ofloxacin compared with those of ampicillin and chloramphenicol." | 7.67 | Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia. ( Borner, K; Kemmerich, B; Pennington, JE, 1987) |
| "Enoxacin, a new 6-fluoroquinolone known to be active in vitro against most common pulmonary pathogens, was evaluated in comparison with ceftazidime, a third generation cephalosporin proven to be effective in the treatment of gram negative pneumonias." | 5.07 | Enoxacin therapy for severe pleuro-pulmonary infections. ( Bansal, MB; Chuah, SK; Mathai, D; Thadepalli, H, 1991) |
| "Ofloxacin (OFLX) or Enoxacin (ENX) was intramuscularly administered at a dose of 100 mg/kg to rats (normal and pneumonia model)." | 3.68 | [The penetration of ofloxacin and enoxacin into the alveolar spaces in rats]. ( Hayashi, Y; Ito, G; Kato, M; Takeuchi, T; Tashiro, T; Yamada, Y; Yamamoto, K; Yoshitomo, K, 1990) |
| "The therapeutic activity of ciprofloxacin, enoxacin, and ofloxacin was evaluated in guinea pigs with acute and chronic experimental Pseudomonas aeruginosa pneumonia." | 3.67 | Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia. ( Kemmerich, B; Pennington, JE; Small, GJ, 1986) |
| "A murine model of bacteremic Haemophilus influenzae type b pneumonia was used to evaluate the therapeutic efficacies of the quinolone antimicrobial agents enoxacin and ofloxacin compared with those of ampicillin and chloramphenicol." | 3.67 | Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia. ( Borner, K; Kemmerich, B; Pennington, JE, 1987) |
| "Enoxacin is a potent quinolone derivative with marked activity against gram-negative bacteria and staphylococci." | 2.66 | Penetration of enoxacin into bronchial secretions. ( Fong, IW; Simbul, M; Vandenbroucke, A, 1987) |
| "Enoxacin is a safe and effective alternative to parenteral treatment of lower respiratory tract infections." | 1.27 | Enoxacin in the treatment of lower respiratory tract infections. ( Arnaud, A; Frances, Y; Nourrit, J; Philip-Joet, F, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miki, F | 1 |
| Saito, A | 1 |
| Tomizawa, M | 1 |
| Nakayama, I | 1 |
| Takebe, K | 1 |
| Takashima, T | 1 |
| Ida, S | 1 |
| Konno, K | 1 |
| Oizumi, K | 1 |
| Sasaki, M | 1 |
| Thadepalli, H | 1 |
| Mathai, D | 1 |
| Bansal, MB | 1 |
| Chuah, SK | 1 |
| Thys, JP | 1 |
| Jacobs, F | 1 |
| Byl, B | 1 |
| Sears, MR | 1 |
| van der Linden, A | 1 |
| Pollock, M | 1 |
| Kato, M | 1 |
| Tashiro, T | 1 |
| Yoshitomo, K | 1 |
| Hayashi, Y | 1 |
| Ito, G | 1 |
| Yamamoto, K | 1 |
| Yamada, Y | 1 |
| Takeuchi, T | 1 |
| Adam, D | 1 |
| Präuer, H | 1 |
| Sörgel, F | 1 |
| Zürcher, J | 1 |
| Klesel, N | 1 |
| Limbert, M | 1 |
| Seibert, G | 1 |
| Winkler, I | 1 |
| Schrinner, E | 1 |
| Kemmerich, B | 2 |
| Small, GJ | 1 |
| Pennington, JE | 2 |
| Philip-Joet, F | 1 |
| Nourrit, J | 1 |
| Frances, Y | 1 |
| Arnaud, A | 1 |
| Fong, IW | 1 |
| Vandenbroucke, A | 1 |
| Simbul, M | 1 |
| Borner, K | 1 |
| Scribner, RK | 1 |
| Welch, DF | 1 |
| Marks, MI | 1 |
1 review available for enoxacin and Pneumonia
| Article | Year |
|---|---|
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Oflox | 1991 |
4 trials available for enoxacin and Pneumonia
| Article | Year |
|---|---|
[Comparative study of the effectiveness of enoxacin and amoxicillin in bacterial pneumonia by a double blind method].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials as | 1984 |
Enoxacin therapy for severe pleuro-pulmonary infections.
Topics: Adult; Ceftazidime; Enoxacin; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; M | 1991 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Oflox | 1991 |
Penetration of enoxacin into bronchial secretions.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchitis; Chromatography, High Pressure Liquid; Enoxacin; Fema | 1987 |
8 other studies available for enoxacin and Pneumonia
| Article | Year |
|---|---|
Mycobacterium fortuitum pneumonia--treatment with enoxacin and cotrimoxazole.
Topics: Adult; Drug Therapy, Combination; Enoxacin; Humans; Male; Mycobacterium Infections, Nontuberculous; | 1991 |
[The penetration of ofloxacin and enoxacin into the alveolar spaces in rats].
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Enoxacin; Ofloxacin; Pneumonia; Pulmo | 1990 |
[Enoxacin concentrations in lung tissue].
Topics: Aged; Enoxacin; Humans; Lung; Male; Middle Aged; Pneumonia; Postoperative Complications | 1989 |
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Klebsiell | 1986 |
Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Guinea Pigs; Kinetics; Naphthyridines; Oflo | 1986 |
Enoxacin in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Drug | 1988 |
Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Enoxacin; Female; Haemophilus Infection | 1987 |
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enoxacin; Mutation; Naphthyrid | 1985 |